INIS
cancer
100%
patients
93%
metastases
41%
kinases
29%
populations
27%
carcinomas
27%
pancreas
27%
adenocarcinomas
20%
reviews
18%
tumors
17%
tyrosine
17%
humans
15%
radiotherapy
15%
therapy
15%
netherlands
15%
drugs
15%
toxicity
15%
risks
14%
evaluation
14%
kidneys
13%
fertility
13%
oocytes
13%
embryos
13%
females
13%
preservation
13%
paintings
13%
carcinogenesis
13%
doses
13%
compliance
13%
glucuronidase
13%
monitoring
13%
lung cells
13%
brain
13%
medical personnel
13%
surveys
13%
breasts
13%
internet
13%
chemotherapy
13%
nephrectomy
10%
quality assurance
9%
control
8%
apoptosis
7%
interventions
7%
metabolism
7%
data
6%
diseases
6%
design
6%
cell cycle
5%
viability
5%
implementation
5%
Keyphrases
Netherlands
13%
Fertility Preservation
13%
Population-based Study
13%
Metastatic Pancreatic Adenocarcinoma
13%
Embryo Cryopreservation
13%
Female Fertility Preservation
13%
Oocyte Cryopreservation
13%
Web-based
13%
Prevalence Factors
13%
Oropharyngeal Dysphagia
13%
Vignette Study
13%
Risk Factors
13%
Cancer Patients
13%
HER2-positive Advanced Breast Cancer
13%
Cognitive Rehabilitation
13%
Expert Survey
13%
Medical Oncologist
13%
Adjuvant Chemotherapy
13%
Trastuzumab Deruxtecan (T-DXd)
13%
Head-and-neck Cancer
13%
Newly Diagnosed
13%
AKT/mammalian Target of Rapamycin
13%
Process Evaluation
13%
Pancreatic Cancer
13%
Global Experts
13%
Cancer Survivors
13%
Brain Metastases
13%
Pancreatic Ductal Adenocarcinoma
11%
Oncologists
8%
Chemotherapy
8%
Immune Checkpoint Inhibitor Combination Therapy
6%
Adjuvant Therapy
5%
Cognitive Difficulties
5%
Rehabilitation Program
5%
Medicine and Dentistry
Head and Neck Cancer
27%
Pancreas Adenocarcinoma
23%
Malignant Neoplasm
15%
Primary Tumor
15%
Nephrectomy
13%
Immunity
13%
Kidney Metastasis
13%
Local Therapy
13%
Cryopreservation
13%
Oocyte
13%
Fertility Preservation
13%
Female Fertility
13%
Adaptive Radiotherapy
13%
Protocol Compliance
13%
Oncologist
13%
Trastuzumab Deruxtecan
13%
Brain Metastasis
13%
Cognitive Rehabilitation
13%
Pancreas Cancer
13%
Adjuvant Chemotherapy
13%
Prevalence
13%
Oropharyngeal Dysphagia
13%
Breast Cancer
13%
Arm
12%
Cohort Analysis
6%
Combination Therapy
6%
Immune Checkpoint Inhibitor
6%
Rehabilitation Engineering
5%
Diseases
5%
Randomized Controlled Trial
5%